A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease

Brief description of study

The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in CD


Clinical Study Identifier: s18-00100
ClinicalTrials.gov Identifier: NCT02914600
Principal Investigator: Blanche Fung Liu
Currently Recruiting

Contact the research team to learn more about this study.


By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.